Other conditions Board decisions

The Board has decided that the change in the Veteran's Means Test eligibility category from copay exempt to copay required for income year 2016 was proper and is remanding the case due to missing documents.

The appeal was dismissed due to the appellant's death, and no final decision can be made.

The Board has decided to remand the case due to a missed VA examination for skin disorder. The Veteran's claim will be reconsidered after scheduling a new examination.

The Veteran's skin disability, specifically dermatophytosis, has been granted a higher initial rating of 30 percent. The condition requires systemic therapy such as corticosteroids or other immunosuppressive drugs for at least 6 weeks but not constantly.

The Board has granted service connection for glioblastoma multiforme, finding that the Veteran's presumed exposure to Agent Orange during his Vietnam-era service is at least as likely as not a cause of his glioblastoma.

The Veteran's service connection claim for chronic diarrhea was granted. The claims for chronic left hip DJD and right hip DJD were denied, as well as the claim for headaches which is being remanded.

The Veteran's cause of death was cardiac arrhythmias, which the Board found to be a form of cardiovascular disease. The service-connected diabetes mellitus is determined to have caused or aggravated his cardiovascular disease, meeting the criteria for DIC based on service connection.

The Veteran's right knee disability, including post-operative status repair and traumatic arthritis, is rated at 10 percent prior to March 5, 2019. The rating for limitation of extension remains at 10 percent from August 4, 2012, to March 4, 2019.

The Board has remanded the case due to non-compliance with previous directives and for obtaining a new retrospective VA medical opinion. The issues of increased rating for supraventricular arrhythmia and TDIU are inextricably intertwined.

The Board has decided to remand the case due to inconsistencies in the appellant's reported medical expenses and discrepancies regarding her income from a private pension. The agency of original jurisdiction is instructed to obtain updated information, verify unreimbursed medical expenses, and request clarification on any ongoing pension income.

The Board has determined that a remand is required to obtain an independent medical opinion regarding the Veteran's claimed dizziness, nausea, and head pressure, as it may be related to his service-connected left ear hearing loss or tinnitus.

The Board has remanded the case due to insufficient evidence regarding the nature and etiology of the Veteran's lymph nodes condition, including whether it is related to service or herbicide exposure.

The Board has determined that the Veteran's pituitary tumor was first present during service and granted service connection for it.

The Board has remanded the case due to new evidence submitted by the Veteran prior to certification of the appeal. The claim will be readjudicated and a supplemental statement of the case (SSOC) will be issued.

The Board has denied the Veteran's claim for service connection for a skin disorder, including seborrheic keratosis and multiple angiomas, as there is no evidence to support that these conditions are related to his military service or exposure to herbicides.

The Board is remanding the case for further development to accurately calculate the Veteran's overpayment and address his challenges related to the amount of his debt.

The Board has remanded the case due to insufficient evidence regarding the etiology of the Veteran's bilateral foot condition. A new VA examination is required.

The Board has remanded the claims for skin condition, bilateral foot condition, and tophaceous gout due to additional development being needed. The VA examiners were instructed to provide a fully reasoned explanation as to whether each condition is related to service.

The appeal was dismissed due to the appellant's death, and no jurisdiction remains for further action.

The Veteran's hypoxia and respiratory residuals of extra gonadal germ cell tumor have been granted a 100 percent rating, effective from the date of the decision.